Thanks to private funding, 100% of every dollar donated to The Lustgarten Foundation goes directly to pancreatic cancer research.

Press Releases

Read current and past press releases outlining the latest news and announcements from The Lustgarten Foundaiton.

2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016  | 2017

2015 Press Releases

DJ Quest Love Performs at 15th Annual Holiday Rock & Roll Bash in Support of the Fight Against Pancreatic Cancer Raising More Than $2 Million
On Wednesday evening, December 16, CablevisionSystems Corporation (NYSE: CVC), The Madison Square Garden Company (NYSE: MSG), andAMC Networks (NASDAQ: AMCX) hosted the 15th annual Holiday Rock & Roll Bash to benefitThe Lustgarten Foundation, the nation’s largest private nonprofit funder of pancreatic cancer research.Held at TAO Downtown in New York City, the event raised more than $2 million for the secondconsecutive year. Due to the support of Cablevision, 100 percent of every dollar raised goes directly topancreatic cancer research. Read More...

Transatlantic Dream Team of Top Researchers Selected To Tackle One of Cancer’s Deadliest Forms: Pancreatic Cancer
Stand Up To Cancer, Cancer Research UK, and The Lustgarten Foundation Fund Team with $12 million

The Stand Up To Cancer – Cancer Research UK–Lustgarten Foundation Dream Team of top cancer researchers from the United States & the United Kingdom was named here today to launch a fresh attack on pancreatic cancer, one of the deadliest forms of cancer on both sides of the Atlantic. Read More...

The Lustgarten Foundation Recognized as a Non-Profit of the Year by the Long Island Business News
The Lustgarten Foundation will be honored by Long Island Business News with a Nonprofit of the Year award, an industry standard for organizations that are dedicated to the economic and social well-being of our community.  Honorees were chosen by a committee of business leaders for their efforts in going above and beyond as outstanding corporate citizens and for their commitment to the greater good. Read More...

The Lustgarten Foundation Grant $19.5 Million for Pancreatic Cancer Research Investigators, Bringin its 2014 Total Contribution to $35 Million
The Lustgarten Foundation, the nation's largest private funder of pancreatic cancer research, today announced that it awarded $19.5 million in research grants to 13 prominent scientists who were nominated by their peers for significant achievements in the field of pancreatic cancer research. Read More...

3D Culture System for Pancreatic Cancer Has Potential to Change Therapeutic Approaches
Today, Cold Spring Harbor Laboratory (CSHL) and The Lustgarten Foundation jointly announce the development of a new model system to grow both normal and cancerous pancreatic cells in the laboratory. Their work offers the potential to change the way pancreatic cancer research is done, allowing scientists to interrogate the pathways driving this devastating disease while searching for new drug targets. Read More...

Hollywood Stands Up To Cancer and Announces a New Major Grant from The Lustgarten Foundation
At last night’s Hollywood Stands Up To Cancer fundraising event, Stand Up To Cancer (SU2C) Co-Founder Katie Couric recognized MasterCard as a SU2C Visionary, a small group of donors who have each contributed more than $25 million. MasterCard then announced its new commitment of $10 million to support SU2C’s innovative cancer research programs. Read More...

New Immunotherapy Clinical Trial Begins With Support from SU2C Pancreatic Cancer Dream Team
Aduro Biotech, Inc. today announced the initiation of an investigator-sponsored Phase 2 clinical trial of the company’s immuno-oncology product candidates GVAX Pancreas and CRS-207 in combination with Bristol-Myers Squibb’s Opdivo (nivolumab), a monoclonal antibody against programmed death-1 receptor (PD-1). The first patient has been enrolled in the trial that will be conducted at up to five U.S. clinical trial sites. Read More...

Cancer Research UK and The Lustgarten Foundation Joins Stand Up To Cancer to Fund New Pancreatic Cancer Dream Team
The American Association for Cancer Research (AACR) is now accepting submissions of ideas for the Stand Up To Cancer (SU2C)-Cancer Research UK-Lustgarten Foundation Pancreatic Cancer Dream Team Translational Research Grant. The grant provides up to $12 million over a three-year period for research on prevention, diagnosis, or treatment of pancreatic cancer by a “Dream Team” of top scientists. Read More...

2015 website development and design sponsored by Celgene

415 Crossways Park Drive, Suite D, Woodbury, NY 11797
Toll Free: 1-866-789-1000 P: 516-737-1550 F: 516-584-6265